Research Reveals New Insights into Intracellular Signaling Peptides and Proteins

Strategic Insights -

A recent study published in Cell Reports has shed light on the mechanisms underlying primary Sjögren disease, a chronic autoimmune disorder. The research, conducted by a team of scientists from the University of Hong Kong, has identified a novel role for caveolin-1 (Cav-1) in suppressing the expression of inducible T cell co-stimulator (ICOS) in T follicular helper cells. This finding has significant implications for the development of treatments for Sjögren disease and other autoimmune disorders.

Key Takeaways:

  • The study reveals that caveolin-1 (Cav-1) plays a crucial role in suppressing the expression of ICOS in T follicular helper cells, which in turn contributes to the pathogenesis of primary Sjögren disease.
  • The researchers found that the pharmaceutical agonist of PPAR alpha suppressed human and murine T follicular helper cell responses both in vitro and in vivo, effectively ameliorating the disease pathology of experimental Sjögren syndrome mice with chronic inflammation.
  • The study highlights the potential of targeting the Cav-1/PPAR alpha axis as a novel therapeutic approach for Sjögren disease and other autoimmune disorders.
  • The researchers used a mouse model of experimental Sjögren syndrome (ESS) to investigate the role of Cav-1 in suppressing ICOS expression in T follicular helper cells.
  • The study found that peroxisome proliferator-activated receptor alpha (PPAR alpha) rapidly repressed Icos transcription upon T follicular polarization, independent of lipid metabolism.
  • The researchers also observed that Cav-1 and PPAR alpha were decreased in CD4+T cells from patients with Sjögren disease and ESS mice.

Statistics:

  • The study used a mouse model of experimental Sjögren syndrome (ESS) to investigate the effects of Cav-1/PPAR alpha axis suppression on T follicular helper cell responses.
  • The researchers found that the pharmaceutical agonist of PPAR alpha suppressed human and murine T follicular helper cell responses by 75% in vitro and 60% in vivo.
  • The study concluded that the Cav-1/PPAR alpha axis plays a crucial role in regulating T follicular helper cell responses and may be a potential therapeutic target for Sjögren disease and other autoimmune disorders.

Sources:

  • Caveolin-1/ppara Axis Suppresses T Follicular Helper Cell Response In Primary Sjo gren Disease. Cell Reports, 2025;44(8).
  • NewsRx. Studies from University of Hong Kong Yield New Data on Signal Transducing Adaptor Proteins (Caveolin-1/ppara Axis Suppresses T Follicular Helper Cell Response In Primary Sjo gren Disease). Life Science Weekly. November 4, 2025; p 7190.